Clinical Pathway Information System Market By Type (Group Order Type, Embodied Variant Type, Reconstructed Information Type) , By Mode of Delivery (On-Premises, Cloud-Based, Web-Based) By End User (Hospitals, Ambulatory Care Centers, Specialty Clinics, Ot
Description
Clinical Pathway Information System Market By Type (Group Order Type, Embodied Variant Type, Reconstructed Information Type) , By Mode of Delivery (On-Premises, Cloud-Based, Web-Based) By End User (Hospitals, Ambulatory Care Centers, Specialty Clinics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Clinical Pathway Information System Market
The clinical pathway information system market was valued at $0.8 billion in 2023 and is projected to reach $1.7 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.
A clinical pathway information system is specialized software designed for healthcare settings to manage and optimize their operations. This system reduces variations in clinical practice and promotes the standardization of multidisciplinary activities. The clinical pathway information system further facilitates the adoption of evidence-based practice in the clinical settings. The major advantage of using such systems includes improved healthcare delivery, swift coordination, data-driven insights, and enhanced efficiency in patient care. The information system efficiently integrates with the electronic healthcare system, enabling quick access to patient data and rapid documentation procedures in the healthcare facilities.
To promote consistency in patient care and ensure standardization of clinical practices in healthcare settings across the globe, there is a significant demand for clinical pathway information systems. In addition, technological advancements facilitate the assimilation of information systems with other healthcare systems, thereby improving the clinical outcomes. This acts as a major driver of the clinical pathway information system market. Moreover, the adoption of information systems is witnessing a surge as they help the healthcare facilities to avoid unnecessary operational costs through improved resource utilization. In the coming future, the convergence of clinical pathway information system and telemedicine is anticipated to be a prominent trend. This convergence is projected to facilitate the transfer of patient data among different healthcare facilities and foster the development of suitable applications that promote remote patient care.
However, the implementation of clinical pathway information system is a highly cost-intensive and intricate process with expenses associated with maintenance & updates and challenges pertaining to assimilation with the existing infrastructure. These factors hamper the growth of the market significantly. Furthermore, complete dependence on technology holds the potential to disrupt the entire workflow at times of system outages and technical issues, deterring several medical facilities from adopting the advanced information systems. On the contrary, upsurge in the utility of electronic health records (EHR) systems among several physicians and doctors is expected to open new avenues for market expansion. According to the statistics published by Statista, a global data and business intelligence platform, approximately 88% of the total doctors were using EHR systems in the U.S. The platform further predicts the figure to rise in the future.
Segment Review
The clinical pathway information system market is segmented into type, mode of delivery, end user, and region. On the basis of type, the market is divided into group order type, embodied variant type, and reconstructed information type. As per mode of delivery, it is classified into on-premises, cloud-based, and web-based. Depending on end user, it is categorized into hospitals, ambulatory care centers, specialty clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Competition Analysis
The key players operating in the global clinical pathway information system market include McKesson Corporation, Civica, GE Healthcare, Koninklijke Philips N.V., EPIC Systems Corporation, Optum, Inc., PointClickCare, Cerner Corporation, Philips Healthcare, and Athenahealth. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.
Key Market Segments
By Type
Group Order Type
Embodied Variant Type
Reconstructed Information Type
By Mode Of Delivery
On-Premises
Cloud-Based
Web-Based
By End User
Hospitals
Ambulatory Care Centers
Specialty Clinics
Others
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
McKesson Corporation
Civica
GE Healthcare
Koninklijke Philips N.V.
EPIC Systems Corporation
Optum, Inc.
PointClickCare
Cerner Corporation
Philips Healthcare
Athenahealth
Table of Contents
216 Pages
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Group Order Type
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Embodied Variant Type
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Reconstructed Information Type
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- CHAPTER 5: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Mode Of Delivery
- 5.2. On-Premises
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Cloud-Based
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Web-Based
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- CHAPTER 6: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Ambulatory Care Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Specialty Clinics
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5. Others
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
- CHAPTER 7: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type
- 7.2.3. Market Size and Forecast, By Mode Of Delivery
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Clinical Pathway Information System Market
- 7.2.6.1. Market Size and Forecast, By Type
- 7.2.6.2. Market Size and Forecast, By Mode Of Delivery
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Clinical Pathway Information System Market
- 7.2.7.1. Market Size and Forecast, By Type
- 7.2.7.2. Market Size and Forecast, By Mode Of Delivery
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Clinical Pathway Information System Market
- 7.2.8.1. Market Size and Forecast, By Type
- 7.2.8.2. Market Size and Forecast, By Mode Of Delivery
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type
- 7.3.3. Market Size and Forecast, By Mode Of Delivery
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Clinical Pathway Information System Market
- 7.3.6.1. Market Size and Forecast, By Type
- 7.3.6.2. Market Size and Forecast, By Mode Of Delivery
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany Clinical Pathway Information System Market
- 7.3.7.1. Market Size and Forecast, By Type
- 7.3.7.2. Market Size and Forecast, By Mode Of Delivery
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy Clinical Pathway Information System Market
- 7.3.8.1. Market Size and Forecast, By Type
- 7.3.8.2. Market Size and Forecast, By Mode Of Delivery
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain Clinical Pathway Information System Market
- 7.3.9.1. Market Size and Forecast, By Type
- 7.3.9.2. Market Size and Forecast, By Mode Of Delivery
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK Clinical Pathway Information System Market
- 7.3.10.1. Market Size and Forecast, By Type
- 7.3.10.2. Market Size and Forecast, By Mode Of Delivery
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Clinical Pathway Information System Market
- 7.3.11.1. Market Size and Forecast, By Type
- 7.3.11.2. Market Size and Forecast, By Mode Of Delivery
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type
- 7.4.3. Market Size and Forecast, By Mode Of Delivery
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Clinical Pathway Information System Market
- 7.4.6.1. Market Size and Forecast, By Type
- 7.4.6.2. Market Size and Forecast, By Mode Of Delivery
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Clinical Pathway Information System Market
- 7.4.7.1. Market Size and Forecast, By Type
- 7.4.7.2. Market Size and Forecast, By Mode Of Delivery
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Clinical Pathway Information System Market
- 7.4.8.1. Market Size and Forecast, By Type
- 7.4.8.2. Market Size and Forecast, By Mode Of Delivery
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Clinical Pathway Information System Market
- 7.4.9.1. Market Size and Forecast, By Type
- 7.4.9.2. Market Size and Forecast, By Mode Of Delivery
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Clinical Pathway Information System Market
- 7.4.10.1. Market Size and Forecast, By Type
- 7.4.10.2. Market Size and Forecast, By Mode Of Delivery
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Clinical Pathway Information System Market
- 7.4.11.1. Market Size and Forecast, By Type
- 7.4.11.2. Market Size and Forecast, By Mode Of Delivery
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type
- 7.5.3. Market Size and Forecast, By Mode Of Delivery
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Clinical Pathway Information System Market
- 7.5.6.1. Market Size and Forecast, By Type
- 7.5.6.2. Market Size and Forecast, By Mode Of Delivery
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa Clinical Pathway Information System Market
- 7.5.7.1. Market Size and Forecast, By Type
- 7.5.7.2. Market Size and Forecast, By Mode Of Delivery
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Clinical Pathway Information System Market
- 7.5.8.1. Market Size and Forecast, By Type
- 7.5.8.2. Market Size and Forecast, By Mode Of Delivery
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Clinical Pathway Information System Market
- 7.5.9.1. Market Size and Forecast, By Type
- 7.5.9.2. Market Size and Forecast, By Mode Of Delivery
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. McKesson Corporation
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Civica
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. GE Healthcare
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Koninklijke Philips N.V.
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. EPIC Systems Corporation
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Optum, Inc.
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. PointClickCare
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Cerner Corporation
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Philips Healthcare
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Athenahealth
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 2. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR GROUP ORDER TYPE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR EMBODIED VARIANT TYPE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR RECONSTRUCTED INFORMATION TYPE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. GLOBAL CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 6. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR ON-PREMISES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR CLOUD-BASED, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR WEB-BASED, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. GLOBAL CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 10. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR SPECIALTY CLINICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. NORTH AMERICA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 16. NORTH AMERICA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 17. NORTH AMERICA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 18. NORTH AMERICA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 19. U.S. CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 20. U.S. CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 21. U.S. CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 22. CANADA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 23. CANADA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 24. CANADA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 25. MEXICO CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 26. MEXICO CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 27. MEXICO CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 28. EUROPE CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 29. EUROPE CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 30. EUROPE CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 31. EUROPE CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 32. FRANCE CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 33. FRANCE CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 34. FRANCE CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 35. GERMANY CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 36. GERMANY CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 37. GERMANY CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 38. ITALY CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 39. ITALY CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 40. ITALY CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 41. SPAIN CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 42. SPAIN CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 43. SPAIN CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 44. UK CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 45. UK CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 46. UK CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 47. REST OF EUROPE CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 48. REST OF EUROPE CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 49. REST OF EUROPE CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 50. ASIA-PACIFIC CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 51. ASIA-PACIFIC CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 52. ASIA-PACIFIC CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 53. ASIA-PACIFIC CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 54. CHINA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 55. CHINA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 56. CHINA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 57. JAPAN CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 58. JAPAN CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 59. JAPAN CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 60. INDIA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 61. INDIA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 62. INDIA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 63. SOUTH KOREA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 64. SOUTH KOREA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 65. SOUTH KOREA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 66. AUSTRALIA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 67. AUSTRALIA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 68. AUSTRALIA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 69. REST OF ASIA-PACIFIC CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 70. REST OF ASIA-PACIFIC CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 71. REST OF ASIA-PACIFIC CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 72. LAMEA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 73. LAMEA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 74. LAMEA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 75. LAMEA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 76. BRAZIL CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 77. BRAZIL CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 78. BRAZIL CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 79. SOUTH AFRICA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 80. SOUTH AFRICA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 81. SOUTH AFRICA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 82. SAUDI ARABIA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 83. SAUDI ARABIA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 84. SAUDI ARABIA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 85. REST OF LAMEA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 86. REST OF LAMEA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY, 2024 - 2033 ($BILLION)
- TABLE 87. REST OF LAMEA CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 88. MCKESSON CORPORATION: KEY EXECUTIVES
- TABLE 89. MCKESSON CORPORATION: COMPANY SNAPSHOT
- TABLE 90. MCKESSON CORPORATION: OPERATING SEGMENTS
- TABLE 91. MCKESSON CORPORATION: PRODUCT PORTFOLIO
- TABLE 92. MCKESSON CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 93. CIVICA: KEY EXECUTIVES
- TABLE 94. CIVICA: COMPANY SNAPSHOT
- TABLE 95. CIVICA: OPERATING SEGMENTS
- TABLE 96. CIVICA: PRODUCT PORTFOLIO
- TABLE 97. CIVICA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 98. GE HEALTHCARE: KEY EXECUTIVES
- TABLE 99. GE HEALTHCARE: COMPANY SNAPSHOT
- TABLE 100. GE HEALTHCARE: OPERATING SEGMENTS
- TABLE 101. GE HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 102. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 103. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
- TABLE 104. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
- TABLE 105. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
- TABLE 106. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
- TABLE 107. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 108. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
- TABLE 109. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
- TABLE 110. EPIC SYSTEMS CORPORATION: OPERATING SEGMENTS
- TABLE 111. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
- TABLE 112. EPIC SYSTEMS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 113. OPTUM, INC.: KEY EXECUTIVES
- TABLE 114. OPTUM, INC.: COMPANY SNAPSHOT
- TABLE 115. OPTUM, INC.: OPERATING SEGMENTS
- TABLE 116. OPTUM, INC.: PRODUCT PORTFOLIO
- TABLE 117. OPTUM, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 118. POINTCLICKCARE: KEY EXECUTIVES
- TABLE 119. POINTCLICKCARE: COMPANY SNAPSHOT
- TABLE 120. POINTCLICKCARE: OPERATING SEGMENTS
- TABLE 121. POINTCLICKCARE: PRODUCT PORTFOLIO
- TABLE 122. POINTCLICKCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 123. CERNER CORPORATION: KEY EXECUTIVES
- TABLE 124. CERNER CORPORATION: COMPANY SNAPSHOT
- TABLE 125. CERNER CORPORATION: OPERATING SEGMENTS
- TABLE 126. CERNER CORPORATION: PRODUCT PORTFOLIO
- TABLE 127. CERNER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 128. PHILIPS HEALTHCARE: KEY EXECUTIVES
- TABLE 129. PHILIPS HEALTHCARE: COMPANY SNAPSHOT
- TABLE 130. PHILIPS HEALTHCARE: OPERATING SEGMENTS
- TABLE 131. PHILIPS HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 132. PHILIPS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 133. ATHENAHEALTH: KEY EXECUTIVES
- TABLE 134. ATHENAHEALTH: COMPANY SNAPSHOT
- TABLE 135. ATHENAHEALTH: OPERATING SEGMENTS
- TABLE 136. ATHENAHEALTH: PRODUCT PORTFOLIO
- TABLE 137. ATHENAHEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL CLINICAL PATHWAY INFORMATION SYSTEM MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF CLINICAL PATHWAY INFORMATION SYSTEM MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN CLINICAL PATHWAY INFORMATION SYSTEM MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCLINICAL PATHWAY INFORMATION SYSTEM MARKET
- FIGURE 10. GLOBAL CLINICAL PATHWAY INFORMATION SYSTEM MARKET SEGMENTATION, BY TYPE
- FIGURE 11. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR GROUP ORDER TYPE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR EMBODIED VARIANT TYPE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR RECONSTRUCTED INFORMATION TYPE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. GLOBAL CLINICAL PATHWAY INFORMATION SYSTEM MARKET SEGMENTATION, BY MODE OF DELIVERY
- FIGURE 15. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR ON-PREMISES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR CLOUD-BASED, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR WEB-BASED, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. GLOBAL CLINICAL PATHWAY INFORMATION SYSTEM MARKET SEGMENTATION, BY END USER
- FIGURE 19. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. CLINICAL PATHWAY INFORMATION SYSTEM MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 27. COMPETITIVE DASHBOARD
- FIGURE 28. COMPETITIVE HEATMAP: CLINICAL PATHWAY INFORMATION SYSTEM MARKET
- FIGURE 29. TOP PLAYER POSITIONING, 2023
- FIGURE 30. MCKESSON CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 31. MCKESSON CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 32. MCKESSON CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 33. CIVICA: NET SALES, 2021-2023 ($BILLION)
- FIGURE 34. CIVICA: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. CIVICA: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. GE HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 37. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. KONINKLIJKE PHILIPS N.V.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 40. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. EPIC SYSTEMS CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 43. EPIC SYSTEMS CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. EPIC SYSTEMS CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. OPTUM, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 46. OPTUM, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. OPTUM, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. POINTCLICKCARE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 49. POINTCLICKCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. POINTCLICKCARE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 51. CERNER CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 52. CERNER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 53. CERNER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 54. PHILIPS HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 55. PHILIPS HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 56. PHILIPS HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 57. ATHENAHEALTH: NET SALES, 2021-2023 ($BILLION)
- FIGURE 58. ATHENAHEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 59. ATHENAHEALTH: REVENUE SHARE, BY REGION, 2023 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
